JH

Justin Hanes

Founder at Theraly Diabetes, Inc.

Baltimore, Maryland

Investor
VC

Invests in

Stages:

Series A
Seed

  • Min Investment:

    $100,000.00

  • Max Investment:

    $5,000,000.00

  • Target Investment:

    $1,500,000.00

Skills

Drug Delivery
Lifesciences
Biotechnology
R&D
Drug Development
Drug Discovery
Technology Transfer
Molecular Biology
Biomedical Engineering
Nanotechnology
Immunology
Chemistry
Biomaterials
Pharmaceutical Industry
Cell Culture
Commercialization
Cell
Life Sciences
Biochemistry
Cell Biology

Education

Lists including Justin

AT
AS
AT
AH

All Series A Investors

14748 people

AM
AT
AS
AR

All Seed Investors

19691 people

Work Experience

Theraly, Inc.

2014

  • Founder

    2014

Theraly Diabetes, Inc.

2014

  • Founder

    2014

GrayBug, LLC

2011

  • Founder, Director, and Former CEO (2011-2013)

    2011

    GrayBug, LLC is a pharmaceutical company focused on the development of drugs to treat diseases that affect vision. GrayBug has two platform delivery technologies, a lead compound through animal efficacy and safety studies in one species for Age-Related Macular Degeneration (AMD), and a pipeline of drugs for other diseases the affect the eye.

KP
Kala Pharmaceuticals

2009

  • Founder and Former Director (2009-2012)

    2009

Wilmer Eye Institute

2009

  • Lewis J. Ort Professor

    2009

JH
Johns Hopkins University

1998

  • Lewis J. Ort Family Professor

    1998